Chondral Defect of the Ankle

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-06
Clinical Trial Update: A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle [Phase 3]
Vericel's MACI is being studied in a Phase 3 trial for symptomatic chondral or osteochondral defects of the ankle in patients aged 17 to 65.…